Physician profile
Ferial Abood
NPI 1184803843
$1,878.23
in general payments reported to CMS, 2019-2025
15 companies · $507 in 2025
The $507 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $279 · 2020: $93.35 · 2021: $284 · 2022: $137 · 2023: $194 · 2024: $384 · 2025: $507.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,037 · Travel and Lodging: $48.79.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,036.68 |
| Travel and Lodging | $48.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $737.55 | 2019-2025 | Grafix Pl, Collagenase Santyl, Stravix Pl |
| Organogenesis INC. | $404.76 | 2020-2025 | Puraply, Puraply Wound Matrix |
| Reapplix INC. | $172.92 | 2024-2025 | 3c Patch Kit - Box |
| Kerecis Limited | $122.42 | 2024-2025 | Kerecis Omega3 Marigen, Kerecis Surgiclose, Kerecis Omega3 Surgiclose |
| Novo Nordisk INC | $103.66 | 2019-2020 | |
| Amgen INC. | $67.62 | 2019-2025 | Repatha, Otezla, Repatha |
| Paratek Pharmaceuticals, INC. | $56.18 | 2025 | Nuzyra, Xhance |
| Hydrofera LLC | $42.90 | 2025 | Leukomed Sorbact |
| Gilead Sciences, INC. | $40.61 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $28.53 | 2019 | |
| Lilly USA, LLC | $28.34 | 2020 | |
| Integra Lifesciences Corporation | $24.39 | 2025 | Tcc-Ez |
| Urgo Medical North America, LLC | $19.43 | 2025 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap, Drawtex Hydroconductive Wound Dressing With Levafiber 4x4, Urgok2 |
| Krystal Biotech INC | $17.85 | 2024 | Vyjuvek |
| Mylan Specialty L.P. | $11.07 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ferial Abood listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.